ArticleFrontiers in cardiovascular medicine2025
Pressure-strain product reflects left ventricular stroke work under a wide range of left ventricular assist device support levels.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sex-specific echocardiographic remodeling and prognostic value of left ventricular sphericity, pressure-dimension index, and myocardial work after durable LVAD implantation.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Assessment of native cardiac function is vital in patients with cardiogenic shock supported by a left ventricular assist device (LVAD), as it is directly related to the critical decision of LVAD management. Left ventricular stroke work (LVSW) can be useful for cardiac assessment to predict survival in cardiogenic shock patients; however, this measurement cannot necessarily be obtained under LVAD support, especially in cases where the aortic valve is closed (i.e., total support). Therefore, we propose a novel echocardiographic parameter named the pressure-strain product (PSP), the product of left ventricular (LV) pressure and LV myocardial strain, as this measurement can be calculated even under LV total support. This study aimed to investigate whether PSP was correlated with pressure-volume (PV) loop-based LVSW and myocardial oxygen consumption under LVAD support. Method: We used 15 adult goats. An LVAD system was established during open chest surgery by draining blood from the left ventricle and returning it to the carotid artery. LV PV loops were analyzed by measuring LV pressure and volume using sonomicrometry. PV loop-based LVSW was defined as the area surrounded by PV loops. The PSP was defined as the product of the peak LV pressure and global circumferential strain (GCS) using speckle-tracking echocardiography. LVAD support levels were divided into three groups: control, and partial (with residual native cardiac output) and total (without native cardiac output) support. Myocardial oxygen consumption was measured using coronary flow and blood gas analyses. The correlation coefficient was measured using linear regression analysis. Results: According to each LVAD support level at control, partial support, and total support, LVSW was 1,748 ± 867, 840 ± 467, and 290 ± 262 mmHg·ml, while PSP was 2,341 ± 507, 1,836 ± 768, and 539 ± 269 mmHg·%, respectively. PSP ( Conclusion: PSP significantly correlated with PV loop-based LVSW at various LVAD support levels. PSP can be a non-invasive parameter for assessing myocardial metabolism under LVAD support, potentially reflecting myocardial oxygen consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.